Geoff Meacham
Stock Analyst at B of A Securities
(3.69)
# 803
Out of 4,876 analysts
253
Total ratings
55%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $43.20 | +25.01% | 6 | Jun 25, 2025 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $72 | $55.26 | +30.29% | 1 | Jun 17, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $42 | $18.14 | +131.60% | 1 | Jun 17, 2025 | |
| ACLX Arcellx | Initiates: Buy | $110 | $65.73 | +67.35% | 1 | Jun 17, 2025 | |
| AMLX Amylyx Pharmaceuticals | Initiates: Buy | $12 | $6.43 | +86.77% | 2 | Jun 17, 2025 | |
| ABOS Acumen Pharmaceuticals | Initiates: Buy | $4 | $1.16 | +246.32% | 4 | Jun 17, 2025 | |
| NVAX Novavax | Initiates: Sell | $6 | $6.31 | -4.91% | 1 | Jun 17, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $70 → $75 | $28.44 | +163.71% | 6 | Jun 10, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $700 → $650 | $524.57 | +23.91% | 22 | Jun 2, 2025 | |
| ABBV AbbVie | Downgrades: Neutral | $210 → $205 | $185.62 | +10.44% | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $43.66 | +0.78% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $50 → $40 | $48.85 | -18.12% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $106.47 | +31.49% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $0.74 | +35.81% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $27.59 | +44.98% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $27.66 | +44.61% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $43.42 | +118.79% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $9.85 | +153.94% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $54.99 | +87.31% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $145 | $125.56 | +15.48% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $279.21 | +5.66% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $48.64 | +74.75% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.79 | +123.46% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $110.84 | +12.78% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $445.35 | +29.11% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $779.53 | +41.11% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $8.86 | +125.73% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $9.58 | +223.59% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.36 | +2,684.74% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $79.16 | +83.17% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $152.75 | +11.29% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $36.03 | +5.48% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $23.20 | +106.90% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $46.29 | +29.62% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.13 | +607.96% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $5.05 | +177.23% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.44 | +47.06% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.52 | +3,190.11% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $24.24 | +85.64% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $2.04 | +1,076.47% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $3.02 | +32.67% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.28 | +2,087.50% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.56 | +6,000.84% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.54 | +1,133.48% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $0.98 | +3,455.83% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.38 | +15,432.54% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.03 | +3,977.67% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $6.51 | +207.22% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.54 | +3,594.81% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $3.40 | +164.71% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $8.22 | +629.93% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $3.73 | +87.92% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $12.58 | +82.90% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $68.11 | +20.39% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $287.35 | -66.94% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.47 | +744.77% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $125.59 | +7.49% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $6.07 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.71 | +2,710.96% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $14.11 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $326.24 | -51.57% | 5 | Nov 8, 2017 |
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $43.20
Upside: +25.01%
Protagonist Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $55.26
Upside: +30.29%
NewAmsterdam Pharma Company
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $18.14
Upside: +131.60%
Arcellx
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $65.73
Upside: +67.35%
Amylyx Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $12
Current: $6.43
Upside: +86.77%
Acumen Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $4
Current: $1.16
Upside: +246.32%
Novavax
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $6.31
Upside: -4.91%
Avidity Biosciences
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $28.44
Upside: +163.71%
Regeneron Pharmaceuticals
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $524.57
Upside: +23.91%
AbbVie
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $185.62
Upside: +10.44%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $43.66
Upside: +0.78%
May 7, 2025
Upgrades: Neutral
Price Target: $50 → $40
Current: $48.85
Upside: -18.12%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $106.47
Upside: +31.49%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.74
Upside: +35.81%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $27.59
Upside: +44.98%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $27.66
Upside: +44.61%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $43.42
Upside: +118.79%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $9.85
Upside: +153.94%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $54.99
Upside: +87.31%
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $125.56
Upside: +15.48%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $279.21
Upside: +5.66%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $48.64
Upside: +74.75%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.79
Upside: +123.46%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $110.84
Upside: +12.78%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $445.35
Upside: +29.11%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $779.53
Upside: +41.11%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $8.86
Upside: +125.73%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $9.58
Upside: +223.59%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.36
Upside: +2,684.74%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $79.16
Upside: +83.17%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $152.75
Upside: +11.29%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $36.03
Upside: +5.48%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $23.20
Upside: +106.90%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $46.29
Upside: +29.62%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.13
Upside: +607.96%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $5.05
Upside: +177.23%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.44
Upside: +47.06%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.52
Upside: +3,190.11%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $24.24
Upside: +85.64%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $2.04
Upside: +1,076.47%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $3.02
Upside: +32.67%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.28
Upside: +2,087.50%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.56
Upside: +6,000.84%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.54
Upside: +1,133.48%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $0.98
Upside: +3,455.83%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.38
Upside: +15,432.54%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.03
Upside: +3,977.67%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $6.51
Upside: +207.22%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.54
Upside: +3,594.81%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $3.40
Upside: +164.71%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $8.22
Upside: +629.93%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $3.73
Upside: +87.92%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $12.58
Upside: +82.90%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $68.11
Upside: +20.39%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $287.35
Upside: -66.94%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.47
Upside: +744.77%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $125.59
Upside: +7.49%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $6.07
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.71
Upside: +2,710.96%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $14.11
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $326.24
Upside: -51.57%